Nordic capital fund CapMan acquires Danfysik's transducer division  

The Nordic capital fund CapMan has acquired the transducer division of the Danish company Danfysik for DKK 64m, writes financial daily newspaper Børsen
The Nordic capital fund CapMan has acquired the transducer division of the Danish company Danfysik for DKK 64m (USD 10.8m), writes financial daily newspaper Børsen. The core business of Danfysik ACP (Advanced Current Products) is the development and production of high-precision transducers and amplifiers, which are used in MRI scanners, an area in which the company is a global market leader. Danfysik ACP also holds a strong position in the market for test and measurement equipment.
MD of Danfysik ACP Henrik Elbæk Pedersen says: "I am very pleased that we now get the opportunity to further develop and grow ACP as an independent company with support from a professional technology investor." Pedersen and the rest of the management will become minority owners of the company.
Tommy Valther Hansen, partner in CapMan and responsible for technology investments in Denmark comments in a press release: "In CapMan we have successfully raised our latest technology fund of about DKK 1bn, and Danfysik ACP is a genuine high-tech company with a unique technology and unique products. We are convinced that ACP's strong position in the market for MRI scanners, where it is a global market leader, provides a good foundation for developing new product types and thus new application opportunities, which create the basis for further growth in the coming years."
In October, Danfysik sealed another deal when it sold its particle therapy division to German industrial giant Siemens for an undisclosed sum. The division manufactures the particle accelerators that form key elements of Siemens Particle Therapy solution, an advanced technology used in cancer treatment.
Link > Danfysik   

Next step

Explore business cases

Please contact me

How can we help you?

We use cookies to make the website perform optimally. You accept cookies by closing the box or continuing to use the website. Click here to read more about cookies. ×